(Hypertension. 2000;35:971.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From The First Department of Internal Medicine, Osaka City University Medical School, Abeno-ku, Osaka, Japan.
Correspondence to Masakazu Kohno, MD, The First Department of Internal Medicine, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545-8586, Japan.
AbstractThe objectives of the present study were (1) to determine whether oxidized LDL and lysophosphatidylcholine (lyso-PtdCho), a major phospholipid component of oxidized LDL, stimulate the migration of cultured human mesangial cells and (2) to investigate the possible effects on mesangial cell migration of the cardiac natriuretic peptides atrial and brain natriuretic peptide (ANP and BNP). Oxidized LDL (10 and 100 µg/mL) and lyso-PtdCho (10-7 to 10-5 mol/L) stimulated migration in a concentration-dependent manner. In contrast, the effects of native LDL and phosphatidylcholine were modest or nonexistent. Protein kinase C (PKC) inhibitor and downregulation of PKC activity by phorbol ester inhibited oxidized LDL and lyso-PtdChoinduced migration. Human ANP(1-28) and human BNP-32 significantly inhibited oxidized LDL and lyso-PtdChoinduced migration in a concentration-dependent manner. C-ANF {des-[Glu18,Ser19,Gly20,Leu21,Gly22]ANP(4-23)}, a specific ligand for ANP clearance receptors, could not inhibit oxidized LDL and lyso-PtdChoinduced migration. Inhibition by ANP and BNP of lyso-PtdChoinduced migration was paralleled by an increase in the cellular level of GMP. Oxidized LDL and lyso-PtdChoinduced migrations were inhibited by 8-bromo-cGMP. The results suggest that oxidized LDL and lyso-PtdCho stimulate the migration of human mesangial cells, at least in part, through a PKC-dependent process and that ANP and BNP inhibit this stimulated migration, probably through a cGMP-dependent process.
Key Words: lysophosphatidylcholines lipoproteins atrial natriuretic factors glomerular mesangium natriuretic peptide, brain
This article has been cited by other articles:
![]() |
A. Damirin, H. Tomura, M. Komachi, J.-P. Liu, C. Mogi, M. Tobo, J.-Q. Wang, T. Kimura, A. Kuwabara, Y. Yamazaki, et al. Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2513 - H2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Yang, C. G. Radu, L. Wang, M. Riedinger, and O. N. Witte Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A Blood, February 1, 2005; 105(3): 1127 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Buschhausen, S. Seibold, O. Gross, T. Matthaeus, M. Weber, and E. Schulze-Lohoff Regulation of mesangial cell function by vasodilatory signaling molecules Cardiovasc Res, August 15, 2001; 51(3): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |